FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

Celldex Therapeutics, Inc.: cash_and_equivalents

One fact, its scope and the complete path back to the official record.

Period: as of 2018-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/e314bada-d50e-4b22-95ec-a4229f2ba682

Reported value

$39.824M{"amount": 39824000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Entity
Celldex Therapeutics, Inc.
Metric
cash_and_equivalents
Period
as of 2018-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001104659-18-031972 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T07:49:49.488008+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0000744218/cash-and-equivalents/2018-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.